VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1648121
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: blood work; Result Unstructured Data: Test Result:normal; Test Name: platelets; Result Unstructured Data: Test Result:normal

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Tiny blood capillaries that burst under the skin on her legs within 4.5 hours of her receiving the Pfizer covid vaccine; petechiae; This is a spontaneous report from a contactable consumer (reported herself). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. Medical history included, hereditary blood disorder from an unknown date and unknown if ongoing, she was allergic to penicillin (She was allergic to penicillin/amoxycillin, which she took 25-26 years ago.) from an unknown date and unknown if ongoing. Concomitant medication included warfarin taken for an unspecified indication, start and stop date were not reported. The patient previously took amoxycillin and experienced swellon throat, amoxycillin for but her throat and experienced broke out in hives, swelled shut and she was allergic to amoxycillin. She had been on a 5-day treatment of amoxycillin/penicillin and required treatment at the hospital. The patient stated that tiny blood capillaries that burst under the skin on her legs within 4.5 hours of her receiving the pfizer covid vaccine and petechiae on an unspecified date. The patient wanted to know whether petechiae was reported before after receiving the Pfizer covid vaccine. The patient would like to know how long she was protected with one dose of the Pfizer covid vaccine, if she needs to hold off on getting the 2nd dose. The patient lab tests included blood test was normal and platelet count was normal on an unspecified date. The outcome of the events was unknown. The reported did not wish to report Follow-up attempts are completed. No further information is expected.

Other Meds: WARFARIN

Current Illness:

ID: 1648122
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: about an hour was rough; chills / shivering; turned into shaking that wouldn't stop; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sales representative. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced that 12 hours after the shot, for about an hour was rough. The patient had chills (but not feverish), shivering and turned into shaking that wouldn't stop. Outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1648123
Sex: F
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: My arthritis has been acting up bad and has spiked; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 72-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunization. Medical history included ongoing arthritis. The patient's concomitant medications were not reported. The patient stated that she was out of medication and her arthritis has been terrible, she just got her COVID shot three weeks ago and on an unspecified date her arthritis has been acting up bad and has spiked. Patient was prescribed with Xeljanz 5mg. The outcome of the event was unknown. Information on the lot batch number has been requested. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness: Arthritis

ID: 1648124
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: headache; This is a spontaneous report from a non-contactable consumer (patient) received via a Pfizer-sponsored program. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced headache on an unspecified date. The outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1648125
Sex: M
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: his lower body (lower back, hips, legs) are ach; his lower body (lower back, hips, legs) are ach; his lower body (lower back, hips, legs) are ach; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age (47: Age, Units: Unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as a Dose 2, single for COVID-19 immunization. The patient's medical history included Type 1 diabetes. The patient's concomitant medications were not reported. The day after getting second dose of Pfizer COVID-19 vaccine, his lower body (lower back, hips, legs) are achy. Event took place after use of product. Reporter does not wish to be contacted for follow-up. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1648126
Sex: U
Age:
State: MI

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: Fever; Result Unstructured Data: Test Result:Low grade fever

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: shoulder pain; low grade fever; This is a spontaneous report received from a contactable consumer. A 43-year-old patient of an unspecified gender received second dose of bnt162b2 (PFIZER/BIONTECH COVID-19 VACCINE, Solution injection), via an unspecified route of administration on 10Feb2021 (at the age of 43-year-old) as single dose for covid-19 immunisation. Patient previously took first dose of bnt162b2 (PFIZER/BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Jan2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were unknown. Patient did not receive any other vaccine within 4 weeks prior to covid vaccine. On the same day, patient experienced shoulder pain for 24 hours and potential low grade fever. The patient underwent lab tests and procedures which included body temperature which showed low grade fever. Therapeutic measures were not taken due to the events. The outcome of the events was recovered on unspecified date. This follow-up is being submitted to notify that the batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.

Other Meds:

Current Illness:

ID: 1648127
Sex: F
Age:
State: UT

Vax Date: 02/18/2021
Onset Date: 02/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Facial swelling at sites of dermal filler; This is a spontaneous report from a contactable nurse (patient). A 38-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via an unspecified route of administration, administered in left arm on 18Feb2021 08:45 (at the age of 38-year-old) as dose 2, single dose for COVID-19 immunisation was in hospital. Medical history included headaches. Patient had no known allergies. Concomitant medication included sumatriptan and cyanocobalamin (B12). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via an unspecified route of administration, administered on an unspecified date as single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID. The patient did not receive other vaccine in four weeks. Post vaccination, the patient had not been tested for COVID. On 19Feb2021 15:00, patient experienced facial swelling at sites of dermal filler. Patient did not receive treatment in response to the event. The outcome of the event was unknown. Follow-up attempts completed. No further information expected.

Other Meds: SUMATRIPTAN; B12 [CYANOCOBALAMIN]

Current Illness:

ID: 1648128
Sex: F
Age:
State: AL

Vax Date: 02/18/2021
Onset Date: 02/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Red erythema; soreness at the site of injection.; Fatigue; headache; myalgias; fever; chills; This is a spontaneous report from a contactable other hcp. A 26-year-old female patient received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection Lot Number: EM9809), via an unspecified route of administration, administered in left arm on 18Feb2021 03:45 (age at vaccination 26-year-old) as single dose for COVID-19 immunisation. Medical history included ehlers-danlos syndrome, psoriasis from an unknown date and unknown if ongoing. She did not have any known allergies. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported. On 19Feb2021 03:00, the patient experienced red erythema, soreness at the site of injection, fatigue, headache, myalgias, fever, chills. Therapeutic measures were taken as a result of red erythema, soreness at the site of injection, fatigue, headache, myalgias, fever, chills. Treatment included Tylenol temporarily relieved arm soreness. It was reported that there was no COVID prior vaccination. and did not had COVID tested post vaccination.The seriousness of events was non-serious. The outcome of all the events was recovered on an unspecified date in 2021. Follow-up attempts are completed. No further information is expected.

Other Meds: ADDERALL

Current Illness:

ID: 1648129
Sex: M
Age:
State: NY

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Fever; Result Unstructured Data: Test Result:101.9 fever

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: lack of tasting hot spice food; have a Tingling right hand slight but noticeable.; 101.9 fever; headache; severe sore body aches for 35 hrs; This is a spontaneous report from a contactable consumer (patient). A 55-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: el 9266, patient was 55-year-old at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 16Feb2021 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included high blood pressure, blood pressure, diabetes, mitral valve prolapse. Concomitant medication(s) included atenolol (ATENOLOL); metformin (METFORMIN); triamterene (TRIAMTERENE); lisinopril (LISINOPRIL); glimepiride (GLIMEPIRIDE) all taken for an unspecified indication, start and stop date were not reported in 2 weeks of vaccination. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: en5318), via an unspecified route of administration, administered in Arm Left on 26Jan2021 at 09:45 as DOSE 1, SINGLE for covid-19 immunisation. No COVID prior vaccination, no COVID tested post vaccination. No known allergies. No other vaccine received in four weeks. Reported that patient had indian food spice level 3 very hot couldn't taste it but can smell and taste most everything else. On 16Feb2021 at 20:00, the patient experienced 101.9 fever, headache, severe sore body aches for 35 hrs, on 19Feb2021, the patient experienced lack of tasting hot spice food, have a tingling right hand slight but noticeable. No treatment for AE received. The patient underwent lab tests and procedures which included Fever resulted as 101.9 fever. The outcomes of events were not recovered. Follow-up (12May2021): Follow-up attempts completed. No further information expected.

Other Meds: ATENOLOL; METFORMIN; TRIAMTERENE; LISINOPRIL; GLIMEPIRIDE

Current Illness:

ID: 1648130
Sex: M
Age:
State: KS

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: sore arm; chills; This is a spontaneous report from a contactable consumer from a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced sore arm, chills on an unspecified date. Reported as, patient took steroids injection after the 1st dose. Patient had no side effects other than a sore arm and on the first shot had few chills on 2nd day. Outcome of all the events were unknown. Follow-up needed. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1648131
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: pain; fever; This is a spontaneous report from a Pfizer. A non-contactable consumer reported for a male patient (friend). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and Expiration Date was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced pain and fever on an unspecified date. Reporter was reported about elderly friend that she was taking care of. Patient had 1st dose of covid vaccine after vaccine had pain and fever. Patient was supposed to get 2nd dose but caller was concerned about getting covid virus and wanted to know what she should do in regards of taking care of elderly person. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1648132
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: only side effect was severe wrist pain, and mild adema on the left hand.; only side effect was severe wrist pain, and mild adema on the left hand.; This is a spontaneous report from a contactable consumer (patient herself) via Pfizer-sponsored program COVAX US Support. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for an unspecified indication. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient's only side effect was severe wrist pain, and mild edema on the left hand. The outcome of the events was unknown. Information on the lot/batch number has been requested. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648133
Sex: F
Age:
State: WI

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: got redness and itchiness on both arms and legs; got redness and itchiness on both arms and legs; This is a spontaneous report from a contactable consumer from a Pfizer sponsored program COVAX US support. The consumer reported for a female patient (mother) who received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on an unknown date in 2021 as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced redness and itchiness on both arms and legs on an unknown date in 2021. Her second dose was schedule on 19Feb2021. The outcome of both the events was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648134
Sex: F
Age:
State: FL

Vax Date: 02/11/2021
Onset Date: 02/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 202102; Test Name: fever; Result Unstructured Data: Test Result:high

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: high fever; This is a spontaneous report from a contactable consumer or other non hcp via Pfizer-sponsored program COVAX US Support. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 11Feb2021 as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced high fever in Feb2021 on last Thursday. The patient underwent lab tests and procedures which included body temperature was high in Feb2021. Reporter would like to know if getting a shot would be contagious with covid for her daughter as they were together. The outcome of the event was unknown. Information about lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1648135
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: a bruise on his left arm after the vaccine shot on his right arm; This is a spontaneous report from a contactable consumer or other non hcp (patient's son) from a Pfizer-sponsored program. A male patient (father of reporter) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Right on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that reporter called on behalf of his father and stated that on an unspecified date the patient experienced a bruise on his left arm after the vaccine shot on his right arm and reporter wanted to know if it's fine. The outcome of the event was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1648136
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Headache; Body aches; Nausea; Fatigue; This is a spontaneous report from a contactable consumer. A 29-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date (reported event took place after use of product), the patient experienced headache, body aches, nausea, and fatigue. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1648137
Sex: F
Age:
State: CA

Vax Date: 02/17/2021
Onset Date: 02/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: muscle and severe joint pain, chills, headache; muscle and severe joint pain, chills, headache; muscle and severe joint pain, chills, headache; muscle and severe joint pain, chills, headache; This is a spontaneous report from a contactable consumer. This 66-years-old female consumer (patient) reported that: A 66-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL9266), via an unspecified route of administration, administered in Arm Left on 17Feb2021 at 18:30 (at the age of 66-year-old) as single dose for covid-19 immunisation. Medical history included mild osteoarthritis and rheumatoid arthritis from an unknown date and unknown if ongoing. Patient had no known allergies. Patient not diagnosed with covid-19 prior to vaccination. Concomitant medication(s) included cholecalciferol (D3); omega 6 triglycerides, omega 9 triglycerides, omega-3 triglycerides (OMEGA 3-6-9); coenzyme q10 [ubidecarenone] (COENZYME Q10 [UBIDECARENONE]) and multivitamin taken for an unspecified indication, start and stop date were not reported. Patient's historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL9265), via an unspecified route of administration, administered in Arm Left on 27Jan2021at 18:45 (at the age of 66-year-old) as single dose for covid-19 immunisation. Patient was not received any other vaccine four weeks prior vaccination. The patient experienced muscle and severe joint pain, chills, headache on 18Feb2021 at 10:00. Since vaccination patient not tested for covid-19. No therapeutic measures were taken as a result of the events. The outcome of the events was reported as recovering. Follow-up attempts completed. No further information expected.

Other Meds: D3; OMEGA 3-6-9; COENZYME Q10 [UBIDECARENONE]

Current Illness:

ID: 1648138
Sex: F
Age:
State: LA

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: difficulty breathing; started feeling warm & progressively got hotter; Felt jittery; shaky; heart rate increased; Felt dizzy as I was walking; started getting fidgety; hands and feet felt tingly; felt like I was burning up inside; Then started sweating/ neck and arms were wet w/sweat; experienced chills; felt nauseated; Tried throwing up; This is a spontaneous report from a contactable other HCP (patient). A 29-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EL9261) via an unspecified route of administration on 25Jan2021 at 13:00 (at the age of 29-years-old) in right arm as a single dose for covid-19 immunization. Medical history included crustacean allergy from an unknown date and unknown if ongoing. The patient did not receive any vaccine on same date or any other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with covid-19. Post vaccination, the patient had not been tested for covid-19. Concomitant medications received in two weeks included methylphenidate hydrochloride (METHYLPHENIDATE HYDROCHLORIDE) and fluoxetine (FLUOXETINE) both taken for an unspecified indication, start and stop date were not reported. On 25Jan2021 at 14:15, after 8-10 minutes of vaccination the patient felt warm and progressively got hotter. Felt jittery, shaky, started getting fidgety, heart rate increased, hands and feet felt tingly, then started sweating, experienced chills, and felt hot. She had difficulty breathing with cloth mask and felt nauseated. Se wanted to take mask off so went to rr and felt dizzy while walking. Neck and arms were wet with sweat, felt like she was burning up inside. She tried throwing up. After few minutes, splashed water on face and went back to waiting area. She again felt jittery, racing heart, and chills. She waited for 15 minutes and left. The patient did not receive any treatment. The outcome of all the events was resolved in 2021. Follow-up attempts completed. No further information expected.

Other Meds: METHYLPHENIDATE HYDROCHLORIDE; FLUOXETINE

Current Illness:

ID: 1648139
Sex: M
Age:
State: MI

Vax Date: 02/17/2021
Onset Date: 02/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: chills; fever; painful headache; neck ache; muscle and joint pain; nausea; extremely tired; muscle and joint pain; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received second dose of bnt162b2 (Pfizer covid-19 vaccine, Solution for injection, Lot unknown: Not available), via an unspecified route in the left arm on 17Feb2021 at 09:30 (age at vaccination: 67-year-old), as a single dose for covid-19 immunization. Medical history included A-fib. Concomitant medications included levothyroxine sodium (LEVOTHYROXIN), telmisartan, apixaban (ELIQUIS) and tamsulosin, al. Historical vaccine included first dose of bnt162b2 (Pfizer covid-19 vaccine, Solution for injection, Lot unknown: unknown), via an unspecified route in the left arm in Jan2021 at 09:30, as a single dose for covid-19 immunization. No known allergies were reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. On 18Feb2021 at 01:00, tired about 16 hrs after the shot patient experienced chills, fever, a painful headache, neck ache, muscle and joint pain, nausea and extremely tired. Patient did not receive any treatment for the events. The clinical outcome of the events was recovered. Follow-up attempts completed. No further information expected.

Other Meds: LEVOTHYROXIN; TELMISARTAN; ELIQUIS; TAMSULOSIN

Current Illness:

ID: 1648140
Sex: U
Age:
State:

Vax Date: 01/23/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: huge problem breathing; feeling like my throat isgetting tight; got sick; This is a spontaneous report from a contactable consumer (patient). A patient with unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration on 23Jan2021 as dose 1, single for Covid-19 immunisation. Patients medical history and concomitant medications were not reported. on an unspecified date patient got sick and was taken to the ER because patient had some small problems a huge problem breathing and felt like throat was getting tight. The outcome of the events was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1648141
Sex: F
Age:
State:

Vax Date:
Onset Date: 02/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: her mom got UTI and her doctor prescribed antibiotic wanted to ask if it will affect the vaccine; This is a spontaneous report from a contactable consumer via a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (2 weeks ago) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 14Feb2021 (2 days ago), the patient got uti and her doctor prescribed antibiotic wanted to ask if it will affect the vaccine. The outcome of the event was unknown. Information about lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1648142
Sex: F
Age:
State: NC

Vax Date: 02/16/2021
Onset Date: 02/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Fever; headache; Tired; nausea; aches; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: en6201), dose 2 via an unspecified route of administration, administered in Arm Right on 16Feb2021 01:15 (at the age of 71-year-old) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (Lot number: el9261) on an unspecified date in Jan2021 01:30 AM for COVID-19 immunization. Facility where the COVID-19 vaccine was administered was other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. On 17Feb2021, patient experienced fever, headache, tired, nausea, aches. There was no treatment for the events. The clinical outcome of events was recovered on an unspecified date in 2021. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648143
Sex: F
Age:
State: TN

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:101 Fahrenheit; Comments: fever

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Caller's wife had a fever of 101F after getting the 1st dose; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a female patient (Reporter's wife). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced caller's wife had a fever of 101f after getting the 1st dose on an unspecified date. The patient underwent lab tests and procedures which included body temperature was 101 Fahrenheit (fever). The outcome of event was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648144
Sex: M
Age:
State: MD

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: he experienced a slight bronchial congestion; cough; This is a spontaneous report from a contactable consumer or other non hcp from a Pfizer-sponsored program Covax US Support. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date, as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that week and half on an unknown date, he got the 1st dose and then he experienced a slight bronchial congestion and cough. The patient just wanted to know what would happen if tested positive for Covid-19 in between the 1st dose and 2nd dose. The clinical outcome of events was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648145
Sex: F
Age:
State: NJ

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: fever; really bad chest pain; This is a spontaneous report from a Pfizer-sponsored program. A contactable female (Patient) consumer or other non-health care professional of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), second dose via an unspecified route of administration on 13Feb2021 single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 13Feb2021 23:00 the patient experienced fever and on an unspecified date of 2021 patient had really bad chest pain. The outcome of the event fever was unknown. The outcome of the event really bad chest pain was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1648146
Sex: F
Age:
State:

Vax Date: 02/13/2021
Onset Date: 02/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: Fever; Result Unstructured Data: Test Result:102

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: body aches; fever of 102; This is a spontaneous report from a non-contactable consumer (patient), from An 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on 13Feb2021 as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, patient got vaccine Yesterday and today started with body aches and fever of 102. Advised that they contact her HCP since she is 83 yr old. The patient underwent lab tests and procedures which included fever (body temperature): 102 on an unspecified date. The outcome of the events was unknown. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1648147
Sex: F
Age:
State: TX

Vax Date: 02/07/2021
Onset Date: 02/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: This is a spontaneous report received from a contactable consumer or other non-healthcare professional. A female patient, of an unspecified age, received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# unknown), via an unspecified route of administration, on Feb 7, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Husband reported on behalf of his wife. Feb 7, 2021 was the first dose of the COVID-19 vaccine. On Feb 12, 2021 patient had a rash and wanted to know if this was a side effect. The outcome of the event: unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648148
Sex: F
Age:
State: OR

Vax Date: 02/19/2021
Onset Date: 02/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: fever; sweating; chills; dizziness; body weakness; extreme fatigue; lymph node swollen and tender; This is a spontaneous report from a contactable consumer. This 33-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIOTECH COVID-19, Solution for injection), via an unspecified route of administration on 19Feb2021 12:00 PM (at the age of 33-year-old) on left arm as dose 1, single for COVID-19 immunisation. Medical history and concomitant medications were not reported. Historic vaccine included bnt162b2 (PFIZER-BIOTECH COVID-19) on 28Jan2021 at 06:45 PM (at the age of 33-year-old) at right arm, dose 1 for COVID-19 immunisation. The patient had not received any other vaccine in four weeks. The patient did not have covid prior vaccination. The patient was not tested positive with covid post vaccination. In Feb2021 at 11:00AM, the patient experienced fever, sweating, chills, dizziness, body weakness, extreme fatigue after 19 hours of vaccination and after 36 hours, lymph node swollen and tender on an unknown date in Feb2021. The patient did not receive any treatment for the events. The outcome of the events was recovering. Information on the lot/batch number has been requested. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648149
Sex: U
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: She had another patient with the exact same rash after the vaccine.; This is a spontaneous report received from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), Solution for injection, via an unspecified route of administration on an unspecified date as unknown single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, patient experienced rash after the vaccine. The outcome of event was unknown. Follow-up attempts completed. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021148608 same reporter, product and AE, different patient

Other Meds:

Current Illness:

ID: 1648150
Sex: F
Age:
State: FL

Vax Date: 02/08/2021
Onset Date: 02/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210209; Test Name: fever; Result Unstructured Data: Test Result:100:1

Allergies:

Symptom List: Nausea

Symptoms: headache; chills; fever 100:1; This is a spontaneous report from a non-contactable consumer (patient) received via Regulatory Agency. A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in the left arm on 08Feb2021, at 11:00 (Lot Number: EC9269, at the age of 74 years old) as dose 2, single for COVID-19 immunisation. Medical history included seasonal allergies, cancer survivor, and two leaky heart valves. The patient has no known allergies and she was not pregnant at the time of report. Concomitant medications included montelukast sodium (SINGULAR), guaifenesin (MUCINEX), and vitamin D. She did not receive any other vaccines within four weeks prior to vaccination. The patient previously received first dose of BNT162B2, administered in the left arm on 18Jan2021, at 14:30 (Lot number: EL8982, at the age of 74 years old) for COVID-19 immunisation. On 09Feb2021, at 07:30, the patient experienced headache, chills, and fever 100:1 (as reported). The patient was not diagnosed with COVID-19 prior to vaccination and she has not been tested for COVID-19 since the vaccination. No therapeutic measures were taken as a result of the events. The patient recovered from the events on an unspecified date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: SINGULAR; MUCINEX; VITAMIN D

Current Illness:

ID: 1648151
Sex: M
Age:
State: MA

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: first dose of the Pfizer vaccine and they were sneezing repeatedly for about 24 hours. They reported that they were sneezing so much that they could hardly work that day; This is a spontaneous report received from a contactable consumer or other non hcp. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number was not reported) via an unspecified route of administration on Jan2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced a friend told me they received the first dose of the Pfizer vaccine and they were sneezing repeatedly for about 24 hours. they reported that they were sneezing so much that they could hardly work that day unspecified date in Jan2021. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1648152
Sex: F
Age:
State: NM

Vax Date: 02/04/2021
Onset Date: 02/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210208; Test Name: Heart rate; Result Unstructured Data: Test Result:elevated; Comments: elevated heart rate, elevated resting heart rate

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Elevated heart rate, elevated resting heart rate, unable to walk outside without heart racing by the time I reach the trash can.; Elevated heart rate, elevated resting heart rate, unable to walk outside without heart racing by the time I reach the trash can.; This is a spontaneous report from a contactable consumer (patient) via COVID-19 Adverse Event Self-Reporting Solution (COVAES). A 54 years old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EM9810), via an unspecified route, administered in Left arm on 04Feb2021 (54-year-old at vaccination) as a Dose 2, single for COVID-19 immunization. The patient was non-pregnant at time of vaccination. The patient's medical history included hypertension and known shellfish allergies. The patient's concomitant medication(s) included carvedilol 25mg 2x/day (twice daily); buspirone 7.5, 2x/day (twice daily); famotidine. The patient previously first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3246), via an unspecified route, administered in Left arm on 15Jan2021 at 13:00 (54-year-old at vaccination) as a Dose 1, single for COVID-19 immunization. Facility type vaccine was reported as Other. The patient had no covid prior vaccination. The patient was not covid tested post vaccination. The patient had not received any other vaccine within 4 weeks of Covid-19 vaccination. On 08Feb2021 at 06:00 AM, the patient had experienced elevated heart rate, elevated resting heart rate, unable to walk outside without heart racing by the time she reached the trash. The patient had not received treatment medication for resulted events. The outcome of the events was not recovered. No follow-up attempts are possible. No further information was expected.

Other Meds: CARVEDILOL; BUSPIRONE; FAMOTIDINE

Current Illness:

ID: 1648153
Sex: F
Age:
State: IL

Vax Date: 01/29/2021
Onset Date: 02/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: stomach burning; Taste metallic; This is a spontaneous report from a contactable consumer (patient). An 80-year-old female patient received bnt162b2 (BNT162B2, Solution for injection, Lot Number: EN5318) via an unspecified route of administration, administered in Arm Right on 29Jan2021 at 13:30 (at the age of 80-year-old) as dose 1, single for COVID-19 immunisation. Patient's Medical History (including any illness at time of vaccination) was reported as no. Concomitant medications were reported as no. History of all previous immunization with the Pfizer vaccine considered as suspect was reported as none. Additional vaccines administered on same date of the Pfizer Suspect was reported as none. Prior Vaccinations (within 4 weeks) was reported as none. Patient family medical history was reported as none. It was reported that the patient received the first dose of the Pfizer COVID 19 vaccine on 29Jan2021 at 13:30 PM in the right arm. She never had any effects after the first dose but then people were telling her that the second shot was really bad. Now she was concerned and wanted to ask about expected side effects for the second shot. The patient was worried about the second shot and noticed a metallic taste in her mouth on 05Feb2021 (reported as starting last Friday) and duration of reaction was reported as 2 days. The patient also experienced stomach burning on 05Feb2021 (reported as starting last Friday). The patient stomach burning was reported as worsened. She was scheduled to get the next dose of the vaccine on 19Feb2021. Relevant test was reported as none. Outcome of the event taste metallic was recovered on 07Feb2021 and for stomach burning was not recovered. Follow-up attempts completed. No further information expected

Other Meds:

Current Illness:

ID: 1648154
Sex: F
Age:
State: NJ

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210210; Test Name: fever; Result Unstructured Data: Test Result:102.0 Fahrenheit

Allergies:

Symptom List: Tremor

Symptoms: 102.0 F fever; fatigue; intermittent shooting sharp headaches; joint stiffness; dull pain (especially in hips, knees, back and fingers)(occurs most frequently with positional changes); intermittent shooting neuropathic pains in legs and feet; general malaise; intermittent sweating (waking up with soaked clothing); This is a spontaneous report from a non-contactable nurse (patient). A non-pregnant 38-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EK9231) via an unspecified route of administration, administered in arm left on 14Jan2021 14:45 (at the age of 38 years old) as dose 2, single for COVID-19 immunisation. Medical history included lyme disease, insulin dependent diabetes and known allergies on watermelon, mayonnaise, penicillin. Concomitant medication included insulin lispro (HUMALOG, via pump as reported). The patient previously received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EK5730) administered on left arm on 23Dec2020 05:00 pm (at the age of 38 years old) as dose 1, single for COVID-19 immunsation and experienced mild fatigue, joint stiffness, and chills for 24 hours 1-day post first vaccine. On 15Jan2021, the patient experienced fatigue even after sleeping 8-10hrs, intermittent shooting sharp headaches (lasting 15- 30seconds), joint stiffness, and dull pain (especially in hips, knees, back and fingers) (occured most frequently with positional changes), intermittent shooting neuropathic pains in legs and feet, and general malaise. The events intermittent dull headaches, intermittent sweating (waking up with soaked clothing), all symptoms are intermittent. Since the patient received the 2nd vaccine, the symptoms have not gone away. On 10Feb2021, 26 days post 2nd vaccine the patient had a 102.0 F fever with only once occurrence. It was reported that the patient had no fevers since. No other vaccine in four weeks, the facility type vaccine was reported as hospital, no COVID prior vaccination and not COVID tested post vaccination. No treatment for the adverse events. The outcome of the event pyrexia was recovered on an unspecified date on 2021; outcome for all the other events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: HUMALOG

Current Illness:

ID: 1648155
Sex: M
Age:
State: NY

Vax Date: 02/05/2021
Onset Date: 02/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: After cardio training day 5 body broke out in rash on left arm and back.; This is a spontaneous report from a contactable consumer (patient). A 50-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: unknown) via an unspecified route of administration on 05Feb2021 at 08:00 (at the age of 50-years-old) in right arm as a single dose for covid-19 immunization. The patient medical history was not reported. The patient previously took doxycycline and experienced drug hypersensitivity. Prior to vaccination, the patient was not diagnosed with covid-19. Post vaccination, the patient had not been tested for covid-19. The patient did not receive any other vaccine in four weeks. Concomitant medication received within two weeks included levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported. The patient reported that after cardio training on day 5 i.e., on 10Feb2021 at 08:00, his body broke out in rash on left arm and back. The patient did not receive any treatment. The outcome of the event was resolving. Follow-up attempts completed. No further information expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1648156
Sex: F
Age:
State: NJ

Vax Date: 02/10/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: painful bumps on tongue; This is a spontaneous report from a contactable consumer. This consumer reported for a 38-year-old female patient (daughter). A 38-year-old female patient received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on 10Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, next day after the vaccination, the patient experienced painful bumps on her tongue. On the day of report, they are less painful, but she still feels it. She is concerned about the next shot. She would like to know should she make the people aware. The outcome of the event was unknown. No follow-up attempts possible. No further information expected. Follow-up (PRD/SRD (11MAY2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.

Other Meds:

Current Illness:

ID: 1648157
Sex: F
Age:
State: TX

Vax Date: 02/07/2021
Onset Date: 02/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210127; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Severe joint pain; Low grade fever; Severe diarrhea; tiredness; This is a spontaneous report from a non-contactable consumer (patient). A non-pregnant 45-year-old female patient received BNT162B2 (PFIZER- 1, single for COVID-19 immunisation. Medical history included High blood pressure, high cholesterol, GERD, and anxiety. Concomitant medications included lisinopril; rosuvastatin calcium (CRESTOR); pantoprazole; celecoxib (CELEBIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration, administered in the right arm on 07Feb2021 13:15 (at the age of 45-years-old), as doseXA [CELECOXIB]); acetylsalicylic acid (BAYER ASPIRIN) all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Severe joint pain, Low grade fever, Severe diarrhea , and Tiredness on 08Feb2021. The patient underwent lab tests and procedures which included SARS-COV-2 test: negative on 27Jan2021. No treatment was received as a result of the events. The outcome of events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LISINOPRIL; CRESTOR; PANTOPRAZOLE; CELEXA [CELECOXIB]; BAYER ASPIRIN

Current Illness:

ID: 1648158
Sex: F
Age:
State:

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210208; Test Name: fever; Result Unstructured Data: Test Result:102 degree

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: 102 degree fever; chills; body trembling; headache; joint pain; swollen lymph nodes on left side; This is a spontaneous report from a non-contactable consumer (patient) received via a reporting program. A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in left arm, on 08Feb2021 at 01:00 PM (Batch/Lot Number: EL9265) (at the age of 32 years old) as dose 2, single for COVID-19 immunisation in a workplace clinic. The patient has no relevant medical history and has no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient was not pregnant at the time of vaccination. There were no concomitant medications. The patient was previously administered the first dose of BNT162B2 on 18Jan2021 at 01:00 PM, single (at the age of 32-years-old) (Lot number: EL1283) in the left arm for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08Feb2021 at 06:00 PM, the patient experienced 102 degree fever, chills and body trembling, headache, joint pain, swollen lymph nodes on left side. All persist even 48 hours after vaccination. The patient underwent lab tests and procedures on 08Feb2021 which included fever: 102 degree. The events did not result to physician office and emergency room visit. The patient did not receive treatment for the events. The patient did not recover from the events on the time of the report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1648159
Sex: F
Age:
State:

Vax Date: 12/31/2020
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Rash 48 hours post 1st and 2nd doses of Covid 19 vaccine. In both instances they resolved within a few days; This is a spontaneous report from a contactable consumer (patient). A 48-years-old female patient received first dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration, administered in Arm Right on 31Dec2020 (Batch/Lot Number: EL3246) and received second dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration, administered in Arm Left on 23Jan2021 (Batch/Lot Number: EL8982) (at the age of 48-years-old) as SINGLE for covid-19 immunization and both were administered at Workplace clinic. Medical history included allergic to mollusks (conch etc) from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Also, the patient did not receive any other medication within two weeks. The patient previously took erythromycin and niacin and experienced allergy. The patient experienced rash 48 hours post 1st and 2nd doses of covid 19 vaccine and in both instances they resolved within a few days. The patient did not received any treatment. The outcome of event was resolved. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648160
Sex: F
Age:
State: NY

Vax Date: 02/08/2021
Onset Date: 02/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210210; Test Name: Covid-19 test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: I developed a swollen lymph node in my arm pit. It is sore and a lump.; I developed a swollen lymph node in my arm pit. It is sore and a lump.; I developed a swollen lymph node in my arm pit. It is sore and a lump.; I've experienced bodyaches; chills; slight fever; nausea; This is a spontaneous report from a non-contactable other health care professional (patient). A 33-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number and expiration date were not reported), via an unspecified route of administration, administered in the right arm on 08Feb2021 01:00 PM (at the age of 33-years-old) as dose 2, single for COVID-19 immunisation at a workplace clinic. Relevant medical history included penicillin allergy. The patient's concomitant medications were not reported. The patient was previously vaccinated with BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in the right arm on 18Jan2021 03: 00 PM as dose 1, single for COVID-19 immunisation. The patient previously took doxycycline (reported as doexyclimine) and experienced allergy. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination. The patient experienced bodyaches, chills, slight fever, nausea on 09Feb2021 03:00 AM and a swollen lymph node in her arm pit, it is sore and a lump on 11Feb2021 01:00 PM (reported as after about 36 hours. No treatment was received for the events. The patient underwent lab tests and procedures which included COVID-19 test (Nasal swab): Negative on 10Feb2021. The outcome of the events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1648161
Sex: F
Age:
State: IN

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Sick; Chills; Feeling terrible; This is a spontaneous report from a contactable consumer. A 72-years-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 10Feb2021 at 11:00 (at the age of 72-years) as dose 1, single in the right arm for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 11Feb2021 at 03:00, the patient experienced sick, chills, feeling terrible. Reporter stated, "She took Tylenol last night about 10 O' clock last night and she took some at 3 O'clock when she woke up in the morning." The outcome of the events was unknown. Information about lot/batch number has been requested. Follow-up (12May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648162
Sex: F
Age:
State:

Vax Date: 02/08/2021
Onset Date: 02/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Difficulty breathing; Extreme flu-like symptoms; Dizzy; Fever; Splitting headache; The worst body aches ever; This is a spontaneous report from a non-contactable consumer (patient). A 36-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9269) via an unspecified route, administered in Right Arm on 08Feb2021 at 07:00 PM (36-year-old at vaccination) as a Dose 2, single for COVID-19 immunization. The patient's medical history included asthma. The patient had known allergies of Erythromycin. The patient's concomitant medications were not reported. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3249) via an unspecified route of administration on 15Jan2021 at 08:00 PM (36-year-old at vaccination) as a Dose 1, single for COVID-19 immunization. Facility type Vaccine was reported as other. The patient had not received an other vaccine within four weeks prior to covid-19 vaccination. The patient was not diagnosed with covid prior to vaccination. The patient was not tested for Covid post vaccination. On 10Feb2021 at 03:00 PM, the patient had experienced extreme flu-like symptoms, dizzy, difficulty breathing, worst body aches ever, fever and splitting headache. No treatment medications were received by the patient for the resulted events. The outcome of the events was recovered on an unknown date in 2021. No follow-up attempts are possible. No further information was expected.

Other Meds:

Current Illness:

ID: 1648163
Sex: F
Age:
State: NJ

Vax Date: 02/06/2021
Onset Date: 02/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Stomach pains; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received bnt162b2 (BNT162B2, solution for injection, Lot Number: EM9809, NDC number was reported as unknown) dose 1 via an unspecified route of administration in left arm on 06Feb2021 16:00 (at the age of 71 years old) as dose 1, single for COVID-19 immunisation. Medical history was none. Concomitant medication was not reported. No other product was given. No investigation assessment was reported. The patient took COVID shot to prevent getting COVID-19. On 09Feb2021 the patient experienced stomach pains. No treatment was given. The patient wanted to know if this was a side effect of the shot and stated that she went to the ER because she thought she was having an intestinal blockage but there was no blockage. The clinical outcome of the event was resolving. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1648164
Sex: F
Age:
State:

Vax Date: 02/06/2021
Onset Date: 02/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:high

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: felt very weak; basically slept all day; runny nose and wooziness; runny nose and wooziness; pressure in the back of the head; Proceeded to belching and flatulance.; Proceeded to belching and flatulance.; This is a spontaneous report from a contactable consumer or other non HCP (Patient). A 71-year-old non pregnant female patient received bnt162b2 (BNT162B2, formulation; Solution for injection), via an unspecified route of administration on 06Feb2021 at 01:30 (Batch/Lot Number: el9269) as DOSE NUMBER UNKNOWN, SINGLE (at the age of 71-year-old) for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included diabetes 2, sleep apnea, high blood pressure from an unknown date and unknown if ongoing. Prior to vaccination the patient not diagnosed with COVID-19. The patient had no known allergies. The patient's concomitant medications were not reported. It was reported that about 30 minutes after the vaccination on 06Feb2021 at 14.00, the patient had pressure in the back of the head and proceeded to belching and flatulence. This event continued for about 2 days and the patient felt better on Monday evening. On 10Feb2021 Wednesday, the patient felt very weak, basically slept all day, had runny nose and wooziness. The patient was not tested for COVID post vaccination. The patient underwent lab tests and procedures which included blood pressure measurement: high on un unknown date. No treatment was received for the events. The outcome of events pressure in the back of the head, proceeded to belching and flatulance reported recovered on 08Feb2021 and for other events outcome was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648165
Sex: F
Age:
State: OK

Vax Date: 01/28/2021
Onset Date: 01/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Cholesterol; Result Unstructured Data: Test Result:high

Allergies:

Symptom List: Vomiting

Symptoms: Burning sensation on left forearm; This is a Spontaneous report from a contactable nurse (patient). A 57-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EL9261, expiry date was unknown), via intramuscular, administered in Arm Right on 28Jan2021 12:00 (at the age of 57-year-old) as dose 1, single for covid-19 immunization. Medical history included High Cholesterol from an unknown date and unknown if ongoing. The patient previously took hepatitis b vaccine and experienced allergies. Prior to the vaccination, the patient was not diagnosed with covid-19. Since the vaccination, the patient had not been tested for covid-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medications within 2 weeks of vaccination. On 31Jan2021 15:00 the patient experienced burning sensation on left forearm. The patient underwent lab tests and procedures which included cholesterol: high on an unspecified date. Therapeutic measures were taken as a result of burning sen-sation on left forearm with triamcinolone cream and using caladryl cream. The outcome of event was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1648166
Sex: F
Age:
State: MO

Vax Date: 01/15/2021
Onset Date: 01/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Patient lymph node in right armpit began to swell starting 48 hours post receiving vaccine; This is a spontaneous report from a contactable pharmacist (patient). A 30-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 intramuscular, administered in Arm Right on 15Jan2021 12:00 (Batch/Lot Number: EL3248) as dose 2, single (Age at vaccination 30-year-old) for covid-19 immunisation. Medical history included from an unknown date. There were no concomitant medications. Historical vaccine information included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) 1st dose on 24Dec2020, intramuscularly administered at 12:00 PM, lot number EL1284 for covid-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Patient did not receive other medications within 2 weeks of vaccination. No known allergies. The patient was not pregnant at the time of vaccination. The patient experienced patient lymph node in right armpit began to swell starting 48 hours post receiving vaccine on 17Jan2021 07:00. Patient lymph node in right armpit began to swell starting 48 hours post receiving vaccine. Swelling lasted one week. The outcome for event was recovered on an unknown date in 2021. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648167
Sex: F
Age:
State: NY

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: a very strong sensitivity to smells; This is a spontaneous report from a contactable consumer (patient herself). A 48-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL3247, expiry date: May2021) via unspecified route of administration, in left arm (left upper arm as reported) on 05Feb2021 09:40 (age at vaccination: 48-years) as dose 1, single for covid-19 immunisation. Medical history included high blood pressure (Why was the patient taking concomitant products Lisinopril HCTZ (Verbatim): high blood pressure) and sensitive to perfumes (Caller wanted to mention that there have been sometimes in her life that she has been a little sensitive to perfumes, but it has been 15 years since she has experienced that) from an unspecified date and unknown if ongoing. It didn't happen enough. She would get a headache from it if someone in the office would come in bathed in perfume. It would almost knock her out. The thing that caught her attention on Friday was because it was normal things in her home that she is accustomed to. There was nothing different about her environment. She couldn't tolerate it. Concomitant medication included ongoing Lisinopril HCTZ 20-12.5mg, 1x/day. There were no prior vaccinations (within 4 weeks). There was no AEs following prior vaccinations. She was calling the number on the COVID19 fact sheet to report side effects after the first dose. She had the first dose Friday last week. The same day as the dose, about 8 hours later, at 17: 40 she noticed a very strong sensitivity to smells. It was almost unbearable. They weren't smelly smells they were good smells like coffee and soap. Things that would not normally bother her at all. She hasn't called her primary care yet, but will do that next. She talked to her doctor before getting the vaccine and was told there was nothing contraindicated in her chart. She was going to call her primary care to get guidance because the second dose was coming up. The outcome of event was recovered on 06Feb2021. Follow-up attempts completed. No further information expected.

Other Meds: LISINOPRIL HCTZ

Current Illness:

ID: 1648168
Sex: F
Age:
State: NJ

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Mild fatigue; Joint stiffness; Chills; This is a spontaneous report received via COVAES. A non-contactable nurse (patient) reported a non-pregnant 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EK5730 and Expiration date: not reported) via an unspecified route of administration, administered on the left arm on 23Dec2020 17:00 (at the age of 38 years old) as dose 1, single for COVID-19 immunisation. The vaccine was administered in a hospital. The patient's medical history included Lyme disease and insulin-dependent diabetes. The patient had known allergies to watermelon, mayonnaise, and penicillin. Concomitant medications included insulin lispro (HUMALOG) via pump for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. On 24Dec2020, one-day post-vaccination, the patient had mild fatigue, joint stiffness, and chills for 24 hours. The patient did not receive treatment and recovered from the reported events on 25Dec2020. No follow-up attempts are possible. No further information is expected.

Other Meds: HUMALOG

Current Illness:

ID: 1648169
Sex: F
Age:
State: MO

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:101.5

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Fever; swollen lymph nodes; severe body aches; headache; fatigue; This is a spontaneous report from a contactable Nurse. A 48-years-old non-pregnant female patient received bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EM9809), intramuscular, administered in Arm Left on 03Feb2021 09:00 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. Medical history included migraine, drug hypersensitivity (Sulfa allergies). There were no concomitant medications. No other vaccine in four weeks and no Other medications in two weeks. No covid prior vaccination and No covid tested post vaccination. The patient experienced fever, swollen lymph nodes, severe body aches, headache, fatigue on 03Feb2021 18:30. Adverse events were reported as 101.5 fever, severe body aches, headache, swollen lymph nodes, fatigue for 2 days. The patient underwent lab tests and procedures which included body temperature: 101.5. The outcome of the events was recovered. No follow-up attempts are possible. No further information is expected. Follow-up (14May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1648170
Sex: F
Age:
State: MA

Vax Date: 02/04/2021
Onset Date: 02/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: medical workup; Result Unstructured Data: Test Result:Normal; Test Name: covid tests; Result Unstructured Data: Test Result:Negative; Comments: has had multiple negative covid tests in past.

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: difficulty concentrating; developed acute, progressive confusion; brain fog; agitation; This is a spontaneous report from a contactable physician. A 95-years-old non pregnant female patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiration date were not reported) intramuscular route of administration, administered in arm left on 04Feb2021 12:00 (age at the vaccination 95-year-old) as dose 2, single for COVID-19 immunization (Nursing Home/Senior Living Facility). The patient medical history was not reported and no prior history of dementia, living alone. Patient had no known allergies. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiration date were not reported) intramuscular route of administration, administered in arm left on 14Jan2021 12:00 as dose 1, single. On 05Feb2021 12:00, the patient had experienced within 24 hours developed acute, progressive confusion- no focal neurologic findings - no fever and stated something happened to me and was aware of her confusion, agitation, difficulty concentrating, knew where she was but did not feel it was the right place, new people and personal information - sx similar to that de-scribed in covid brain fog after infection. The patient underwent lab tests and procedures which included medical workup as normal, sars-cov-2 test as negative on has had multiple negative covid tests in past on unspecified date. The patient did not receive treatment for the adverse event. No other vaccine in four weeks. Ae resulted in: Doctor or other healthcare professional office/clinic visit. Patient had not been diagnosed with COVID-19 prior to vaccination and unknown if covid tested post vaccination. The outcome of the events was not recovered. Follow-up attempts completed. No further information expected.

Other Meds: EFFEXOR; SYNTHROID

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am